Health

Results: 1765-1776 of 10166

PR Newswire associated0

New guidance on surgical gloving to aid hand health of surgical teams and improve clinical outcomes

Sobi Q1 2026 report: Strong execution and pipeline momentum

CARB-X awards funding to AdJane to advance its nOMV platform-derived vaccine for the prevention of gonorrhea

Business Wire logo

AviadoBio Announces Agreement with Apertura Gene Therapy to License TfR1 CapX™, a Next-Generation Blood-Brain Barrier-Crossing Capsid

PR Newswire associated0

Proteotype Diagnostics Selected for EU-Funded HER-CARE Doctoral Network, Signalling Growing Research Leadership in Precision Oncology

SciBase publishes the Annual report for 2025

Bioretec Ltd - Manager's transactions - Paavola

PCI Pharma Services announced a series of major infrastructure investments that substantially deepen its sterile fill-finish and advanced drug delivery capabilities.

Backed by Investments Exceeding $1 Billion, PCI Pharma Services Announces Major Expansion of US Sterile Fill-Finish and Drug-Device Delivery Combination Capabilities

Taiho Oncology, Taiho Pharmaceutical and Araris Biotech AG Advance ADC ARC-02 into Phase 1 Clinical Development

vVARDIS Announces Investment from Apollo —Achieves Unicorn Status

Business Wire associated0

Peloton’s World-Class Content to Fuel Spotify’s New Fitness Category Globally

Business Wire logo

Mundipharma announces positive topline results from Phase III ReSPECT trial assessing ▼REZZAYO® (rezafungin) for the prophylaxis of invasive fungal diseases in allogeneic haematopoietic stem cell transplantation patients